Technology One Ltd (TNE)
Australian Securities Exchange · Australia · prices in AUD · close of 23 Oct 2026
Key indicators
| Last close | AUD 32.25 |
|---|---|
| 52-week range | 20.14 – 39.13 |
| Return, 1 month / 3 months | +11.1% / +14.3% |
| Return, 1 year / 3 years | −15.0% / +119.5% |
| Trend | Uptrend |
| RSI (14) | 62 |
| Volatility (1 year) | 44.3% |
| Worst drawdown (1 year) | -47.2% |
| Average daily value traded | 23.69M AUD |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Technology One is an Australian software company based in Brisbane that develops and supplies enterprise resource planning software to organisations. Its products cover finance, human resources, payroll, supply chain and student management, and are used by customers in government, education, health and large businesses. The company provides its software as a subscription service and also offers implementation and support services to help organisations run their core administrative systems.
Technology One Ltd trades under the code TNE on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Technology One Ltd (TNE) trades on the Australian Securities Exchange in Australia. It last closed at AUD 32.25 on 23 October 2026.
Its price-based Market X-Ray is 75 out of 100 (a strong price profile), ranking 219 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.0% and over the last three months it rose 14.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 12.0% | ||
| From 52-week high | -16.7% | ||
| Momentum | 71 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.3% | ||
| 6-month return | 8.6% | ||
| 12-month return, skipping the last month | -23.5% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 44.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.2% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 23.69M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.1% |
|---|---|
| 1 month | +11.1% |
| 3 months | +14.3% |
| 6 months | +8.6% |
| 1 year | −15.0% |
| 3 years | +119.5% |
| 5 years | +176.5% |
Signals
| 50-day / 200-day average | 30.67 / 28.81 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 28 May 2026 | AUD 0.0800 |
| 27 Nov 2025 | AUD 0.3000 |
| 29 May 2025 | AUD 0.0660 |
| 28 Nov 2024 | AUD 0.1737 |
| 30 May 2024 | AUD 0.0508 |
| 30 Nov 2023 | AUD 0.1490 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.